0000950170-25-021237.txt : 20250214 0000950170-25-021237.hdr.sgml : 20250214 20250214161508 ACCESSION NUMBER: 0000950170-25-021237 CONFORMED SUBMISSION TYPE: SCHEDULE 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20250214 DATE AS OF CHANGE: 20250214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: TRINITY BIOTECH PLC CENTRAL INDEX KEY: 0000888721 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-44122 FILM NUMBER: 25628931 BUSINESS ADDRESS: STREET 1: IDA BUSINESS PARK, BRAY, CO WICKLOW STREET 2: IRELAND CITY: DUBLIN IRELAND STATE: L2 ZIP: 18 BUSINESS PHONE: 01135312955111 MAIL ADDRESS: STREET 1: 3 ROCK ROAD STREET 2: SANDYFORD INDUSTRIAL ESTATES CITY: DUBLIN IRELAND STATE: L2 ZIP: 18 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: PERCEPTIVE ADVISORS LLC CENTRAL INDEX KEY: 0001224962 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13D/A BUSINESS ADDRESS: STREET 1: 51 ASTOR PLACE, 10TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10003 BUSINESS PHONE: 646-205-5300 MAIL ADDRESS: STREET 1: 51 ASTOR PLACE, 10TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10003 SCHEDULE 13D/A 1 primary_doc.xml SCHEDULE 13D/A 0001193125-24-258807 0001224962 XXXXXXXX LIVE 3 Class A Ordinary Shares, $0.0109 par value per share 12/31/2024 false 0000888721 896438504 Trinity Biotech plc

IDA Business Park Bray Co. Wicklow L2 A98 H5C8

Alexander Rakitin (646) 205-5340 Perceptive Advisers LLC 51 Astor Place, 10th Floor New York NY 10003 With copies to Louis Rambo (202) 416-6878 Proskauer Rose LLP 1001 Pennsylvania Avenue, NW Suite 600 South Washington DC 20004 0001224962 N Perceptive Advisors LLC b AF Y DE 0 85800000 0 85800000 85800000 N 20.9 OO 0001877081 N Perceptive Credit Advisors LLC b AF Y DE 0 85800000 0 85800000 85800000 N 20.9 OO 0001164426 N Joseph Edelman b AF Y X1 0 85800000 0 85800000 85800000 N 20.9 IN Y Perceptive Credit Holdings II, L.P. b WC Y DE 0 45800000 0 45800000 45800000 N 11.4 PN 0001877078 N Perceptive Credit Holdings III, L.P. b WC Y DE 0 40000000 0 40000000 40000000 N 9.7 PN Class A Ordinary Shares, $0.0109 par value per share Trinity Biotech plc IDA Business Park Bray Co. Wicklow L2 A98 H5C8 Items 5(a)-(b) of the Schedule 13D is amended and supplemented as follows: The information set forth in rows 11 and 13 of the cover pages to this Amendment No. 3 to the Schedule 13D is incorporated by reference. The percentage set forth in row 13 is based on 361,073,562 Ordinary Shares outstanding as of November 30, 2024, as reported in the Issuer's prospectus filed pursuant to Rule 424(b)(3) with the Securities and Exchange Commission on December 5, 2024, and, with respect to Credit Fund II, assumes the exercise of 500,000 Warrants held by Credit Fund II into 500,000 ADSs representing 10,000,000 Ordinary Shares, and with respect to Credit Fund III, assumes the exercise of 2,000,000 Warrants held by Credit Fund III into 2,000,000 ADSs representing 40,000,000 Ordinary Shares. The information set forth in rows 7 through 10 of the cover pages to this Amendment No. 3 to the Schedule 13D is incorporated by reference. Perceptive Advisors LLC /s/ Joseph Edelman 02/14/2025 Perceptive Credit Advisors LLC /s/ Joseph Edelman 02/14/2025 Joseph Edelman /s/ Joseph Edelman 02/14/2025 Perceptive Credit Holdings II, L.P. /s/ Joseph Edelman 02/14/2025 Perceptive Credit Holdings III, L.P. /s/ Joseph Edelman 02/14/2025